Navigation Links
Biomira Announces Plan to Reincorporate in the United States
Date:9/12/2007

an of arrangement and the shares to be issued to Biomira's shareholders in the plan of arrangement. Assuming that the SEC declares the registration statement effective, the shareholders approve of the plan of arrangement, and the Alberta Court of Queen's Bench issues a final order approving the plan of arrangement, Biomira currently estimates that the transactions contemplated by the plan of arrangement should be completed in early 2008.

About Biomira

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.

Conference Call and Webcast

Biomira's management will hold a conference call beginning at 10:00 a.m. EDT today, September 12, 2007. To listen to a live webcast of the call, visit http://www.biomira.com. Biomira intends to make a recording of the webcast available on the Biomira website and via telephone replay. It is expected that the archive of the webcast will be available approximately 15 minutes after completion of the discussion and will be posted for 90 days. It is expected that a replay will be available by phone approximately one hour after completion of the discussion and will be accessible for 7 days. Access numbers for this replay are:

416-640-1917, passcode 21246399 followed by the pound sign or

877-289-8525, passcode 21246399 followed by the pound sign

Forward Looking Statements

In order to provide Biomira's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements relating to the anticipated benefits of the proposed reincorporation of Biomira from Canada to the United States. These forward-looking state
'/>"/>

SOURCE Biomira Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... -- Sequenom, Inc. (NASDAQ: SQNM ), a ... announced that a new publication from the large Women ... for Molecular Medicine,s (Sequenom CMM) MaterniT21 PLUS ... peer-reviewed journal, Prenatal Diagnosis . Along with this ... week ended May 12, 2012, Sequenom CMM has processed ...
(Date:5/17/2012)... 16, 2012  In an effort to voice concern ... (PIDD), the Immune Deficiency Foundation (IDF) offered oral testimony ... Administration (FDA) public hearing on draft guidance of biosimilars ... therapies from the biosimilars pathways in order to protect ... PIDD occurs in people born with an immune system ...
(Date:5/16/2012)... able to reach for and sip from a drink on ... years by using her thoughts to direct a robotic ... Institutes of Health, is evaluating the safety and feasibility of ... This is a type of brain-computer interface (BCI) intended to ... , A report published today in Nature describes ...
(Date:5/16/2012)... May 16, 2012 Reportlinker.com ... report is available in its catalogue: ... http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_ ... markets for Biotechnology Instrumentation in US$ ... DNA Synthesizers, Protein/Peptide Synthesizers, DNA Sequencers, ...
Breaking Biology Technology:Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 2Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 3Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 4Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets 5Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway 2Paralyzed individuals use thought-controlled robotic arm to reach and grasp 2Paralyzed individuals use thought-controlled robotic arm to reach and grasp 3Paralyzed individuals use thought-controlled robotic arm to reach and grasp 4Paralyzed individuals use thought-controlled robotic arm to reach and grasp 5Global Biotechnology Instrumentation Industry 2Global Biotechnology Instrumentation Industry 3Global Biotechnology Instrumentation Industry 4Global Biotechnology Instrumentation Industry 5Global Biotechnology Instrumentation Industry 6Global Biotechnology Instrumentation Industry 7Global Biotechnology Instrumentation Industry 8Global Biotechnology Instrumentation Industry 9Global Biotechnology Instrumentation Industry 10Global Biotechnology Instrumentation Industry 11Global Biotechnology Instrumentation Industry 12Global Biotechnology Instrumentation Industry 13Global Biotechnology Instrumentation Industry 14Global Biotechnology Instrumentation Industry 15Global Biotechnology Instrumentation Industry 16Global Biotechnology Instrumentation Industry 17Global Biotechnology Instrumentation Industry 18Global Biotechnology Instrumentation Industry 19Global Biotechnology Instrumentation Industry 20
... an economic environment where many healthcare providers are ... patients are thriving with help from InstaMed. ... and platform, Prime Health Network has increased patient ... while also improving the patient experience at each ...
... biotechnology company delivering breakthrough therapies in central nervous system ... participating at two upcoming healthcare investor conferences. Dr. Steve ... 2nd Annual BIO Venture Conference on April 1 at ... Boston, MA. On April 9 at 11:30 a.m. PDT, ...
... Shire plc (LSE: SHP, NASDAQ:, SHPGY ), the ... Accounts in respect of the year ended December 31, ... announced unaudited full,year 2008 results, prepared in accordance with ... announcement on February 19,2009. , ...
Other Biology Technology:Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network 2Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network 3Accera, Inc. to Present at Upcoming Investor Conferences 2Publication of Shire plc's Annual Report 2008 2Publication of Shire plc's Annual Report 2008 3Publication of Shire plc's Annual Report 2008 4Publication of Shire plc's Annual Report 2008 5Publication of Shire plc's Annual Report 2008 6Publication of Shire plc's Annual Report 2008 7Publication of Shire plc's Annual Report 2008 8Publication of Shire plc's Annual Report 2008 9Publication of Shire plc's Annual Report 2008 10Publication of Shire plc's Annual Report 2008 11Publication of Shire plc's Annual Report 2008 12Publication of Shire plc's Annual Report 2008 13Publication of Shire plc's Annual Report 2008 14Publication of Shire plc's Annual Report 2008 15Publication of Shire plc's Annual Report 2008 16Publication of Shire plc's Annual Report 2008 17Publication of Shire plc's Annual Report 2008 18Publication of Shire plc's Annual Report 2008 19Publication of Shire plc's Annual Report 2008 20Publication of Shire plc's Annual Report 2008 21Publication of Shire plc's Annual Report 2008 22Publication of Shire plc's Annual Report 2008 23Publication of Shire plc's Annual Report 2008 24Publication of Shire plc's Annual Report 2008 25Publication of Shire plc's Annual Report 2008 26Publication of Shire plc's Annual Report 2008 27Publication of Shire plc's Annual Report 2008 28Publication of Shire plc's Annual Report 2008 29Publication of Shire plc's Annual Report 2008 30Publication of Shire plc's Annual Report 2008 31Publication of Shire plc's Annual Report 2008 32Publication of Shire plc's Annual Report 2008 33
(Date:5/21/2012)... team of scientists from the National University of Singapore,s ... discovered how a drug-led compound a compound that ... can deprive cancer cells of energy and stop them ... named BPTES. , This is the first time ... drug-lead compound suppresses tumour formation. , Building on ...
(Date:5/21/2012)... , , , , , ... , , , , , ... thanks to breakthrough research by CSIRO researchers who have supercharged safflower to produce increased amounts... , , ... , , , , , ... , , , , , , , , ...
(Date:5/20/2012)... melody, the male songbird uses a trial-and-error process to mimic ... over again, hundreds of times a day, making subtle changes ... finch, this rigorous training process begins around the age of ... he becomes sexually mature and ready to use his song ... brain must receive and process large quantities of information about ...
Breaking Biology News(10 mins):Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2Supercharged safflower 2Supercharged safflower 3Supercharged safflower 4Songbirds' learning hub in brain offers insight into motor control 2Songbirds' learning hub in brain offers insight into motor control 3Luminex Corporation Reports Second Quarter 2011 Results 19401 1Luminex Corporation Reports Second Quarter 2011 Results 19401 2Luminex Corporation Reports Second Quarter 2011 Results 19401 3Luminex Corporation Reports Second Quarter 2011 Results 19401 4Luminex Corporation Reports Second Quarter 2011 Results 19401 5Luminex Corporation Reports Second Quarter 2011 Results 19401 6Luminex Corporation Reports Second Quarter 2011 Results 19401 7Luminex Corporation Reports Second Quarter 2011 Results 19401 8Luminex Corporation Reports Second Quarter 2011 Results 19401 9NeurogesX Inc Secures 2420 Million Debt Facility 19398 1NeurogesX Inc Secures 2420 Million Debt Facility 19398 2NeurogesX Inc Secures 2420 Million Debt Facility 19398 3NeurogesX Inc Secures 2420 Million Debt Facility 19398 4As Heart Failure Worsens Word Recall May Suffer Too 84250 1
... flavanols, the unique compounds found naturally in cocoa, may ... research published in the Neuropsychiatric Disease and Treatment journal. ... flow could impact cognitive behavior, offering future potential for ... a scientific study of healthy, older adults ages 59 ...
... entrepreneurial geneticist Craig Venter sailed around the world on ... ambitious project to use genetics to understand invisible ecological ... jumble of mystery DNA fragments belonging to thousands of ... University of Washington scientist has studied lake mud, which ...
... the sweeping destruction of the 1918 flu pandemic, researchers at ... to the virus from elderly survivors of the original ... long-lasting immunity to such viruses, these antibodies could be effective ... the 1918 flu breaks out in the future. , ...
Other Biology News:Researchers link cocoa flavanols to improved brain blood flow 2Researchers link cocoa flavanols to improved brain blood flow 3Cataloguing invisible life: Microbe genome emerges from lake sediment 2Cataloguing invisible life: Microbe genome emerges from lake sediment 31918 flu antibodies resurrected from elderly survivors 2
... Agencourt offers single pass sequencing ... service is fueled by our high ... 20 million Phred20 bases per day. ... single pass sequencing customers are rapid ...
GLP-compliant, CLIA-certified DNA sequencing service. ASQ and SQA certified quality assurance staff. Auditors welcome....
...
... calibration, and validation (MCV) plate ... plate used for hands-free startup, ... using the Bio-Plex suspension array ... for use with Bio-Plex Manager ...
Biology Products: